APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI-based Clinical Trial Solution

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI-based Clinical Trial Solution Market Analysis and Forecast 2026-2032

15 January 2026201 pages

Choose your research edition.

Industry ResearchAI-based Clinical Trial Solution Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal AI-based Clinical Trial Solution Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal AI-based Clinical Trial Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI-based Clinical Trial Solution Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal AI-based Clinical Trial Solution Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global AI-based Clinical Trial Solution market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI-based Clinical Trial Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI-based Clinical Trial Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI-based Clinical Trial Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI-based Clinical Trial Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI-based Clinical Trial Solution include AiCure, Antidote, Deep Lens, Saama Technologies, Trials.ai, Deep 6 AI, Innoplexus, Median Technologies and Mendel.ai, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI-based Clinical Trial Solution, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI-based Clinical Trial Solution, also provides the revenue of main regions and countries. Of the upcoming market potential for AI-based Clinical Trial Solution, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI-based Clinical Trial Solution revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI-based Clinical Trial Solution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI-based Clinical Trial Solution revenue, projected growth trends, production technology, application and end-user industry.

AI-based Clinical Trial Solution Segment by Company

AiCure

Antidote

Deep Lens

Saama Technologies

Trials.ai

Deep 6 AI

Innoplexus

Median Technologies

Mendel.ai

Phesi

Tempus

IBM

Digital Reasoning

Insilico Medicine

Insitro

Evotec

PathAI

Cancer Center.ai

AI-based Clinical Trial Solution Segment by Type

Artificial Narrow Intelligence

Artificial General Intelligence

Artificial Super Intelligence

AI-based Clinical Trial Solution Segment by Application

Drug Discovery

Drug Manufacturing

Drug Marketing

Diagnosis and Treatment

Clinical Trials

AI-based Clinical Trial Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-based Clinical Trial Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-based Clinical Trial Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-based Clinical Trial Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI-based Clinical Trial Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI-based Clinical Trial Solution company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI-based Clinical Trial Solution revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI-based Clinical Trial Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Artificial Narrow Intelligence Major Player Table 3. Artificial General Intelligence Major Player Table 4. Artificial Super Intelligence Major Player Table 5. Global AI-based Clinical Trial Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Drug Discovery Major Player Table 7. Drug Manufacturing Major Player Table 8. Drug Marketing Major Player Table 9. Diagnosis and Treatment Major Player Table 10. Clinical Trials Major Player Table 11. AI-based Clinical Trial Solution Industry Trends Table 12. AI-based Clinical Trial Solution Industry Drivers Table 13. AI-based Clinical Trial Solution Industry Opportunities and Challenges Table 14. AI-based Clinical Trial Solution Industry Restraints Table 15. Global AI-based Clinical Trial Solution Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global AI-based Clinical Trial Solution Market Size by Region (2021-2026) & (US$ Million) Table 17. Global AI-based Clinical Trial Solution Market Share by Region (2021-2026) Table 18. Global AI-based Clinical Trial Solution Market Size by Region (2027-2032) & (US$ Million) Table 19. Global AI-based Clinical Trial Solution Market Share by Region (2027-2032) Table 20. Global AI-based Clinical Trial Solution Revenue by Players (US$ Million) & (2021-2026) Table 21. Global AI-based Clinical Trial Solution Revenue Market Share by Players (2021-2026) Table 22. Global AI-based Clinical Trial Solution Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global AI-based Clinical Trial Solution Key Players Headquarters & Area Served Table 24. Global AI-based Clinical Trial Solution Players, Product Type & Application Table 25. Global AI-based Clinical Trial Solution Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global AI-based Clinical Trial Solution by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global AI-based Clinical Trial Solution Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global AI-based Clinical Trial Solution Revenue by Type (2021-2026) & (US$ Million) Table 30. Global AI-based Clinical Trial Solution Revenue by Type (2027-2032) & (US$ Million) Table 31. Global AI-based Clinical Trial Solution Revenue Market Share by Type (2021-2026) Table 32. Global AI-based Clinical Trial Solution Revenue Market Share by Type (2027-2032) Table 33. Global AI-based Clinical Trial Solution Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global AI-based Clinical Trial Solution Revenue by Application (2021-2026) & (US$ Million) Table 35. Global AI-based Clinical Trial Solution Revenue by Application (2027-2032) & (US$ Million) Table 36. Global AI-based Clinical Trial Solution Revenue Market Share by Application (2021-2026) Table 37. Global AI-based Clinical Trial Solution Revenue Market Share by Application (2027-2032) Table 38. AiCure Company Information Table 39. AiCure Business Overview Table 40. AiCure AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. AiCure AI-based Clinical Trial Solution Product Portfolio Table 42. AiCure Recent Development Table 43. Antidote Company Information Table 44. Antidote Business Overview Table 45. Antidote AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Antidote AI-based Clinical Trial Solution Product Portfolio Table 47. Antidote Recent Development Table 48. Deep Lens Company Information Table 49. Deep Lens Business Overview Table 50. Deep Lens AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Deep Lens AI-based Clinical Trial Solution Product Portfolio Table 52. Deep Lens Recent Development Table 53. Saama Technologies Company Information Table 54. Saama Technologies Business Overview Table 55. Saama Technologies AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Saama Technologies AI-based Clinical Trial Solution Product Portfolio Table 57. Saama Technologies Recent Development Table 58. Trials.ai Company Information Table 59. Trials.ai Business Overview Table 60. Trials.ai AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Trials.ai AI-based Clinical Trial Solution Product Portfolio Table 62. Trials.ai Recent Development Table 63. Deep 6 AI Company Information Table 64. Deep 6 AI Business Overview Table 65. Deep 6 AI AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Deep 6 AI AI-based Clinical Trial Solution Product Portfolio Table 67. Deep 6 AI Recent Development Table 68. Innoplexus Company Information Table 69. Innoplexus Business Overview Table 70. Innoplexus AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Innoplexus AI-based Clinical Trial Solution Product Portfolio Table 72. Innoplexus Recent Development Table 73. Median Technologies Company Information Table 74. Median Technologies Business Overview Table 75. Median Technologies AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Median Technologies AI-based Clinical Trial Solution Product Portfolio Table 77. Median Technologies Recent Development Table 78. Mendel.ai Company Information Table 79. Mendel.ai Business Overview Table 80. Mendel.ai AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Mendel.ai AI-based Clinical Trial Solution Product Portfolio Table 82. Mendel.ai Recent Development Table 83. Phesi Company Information Table 84. Phesi Business Overview Table 85. Phesi AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Phesi AI-based Clinical Trial Solution Product Portfolio Table 87. Phesi Recent Development Table 88. Tempus Company Information Table 89. Tempus Business Overview Table 90. Tempus AI-based Clinical Trial Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Tempus AI-based Clinical Trial Solution Product Portfolio Table 92. Tempus Recent Development Table 93. IBM Company Information Table 94. IBM Business Overview Table 95. IBM AI-based Clinical Trial Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. IBM AI-based Clinical Trial Solution Product Portfolio Table 97. IBM Recent Development Table 98. Digital Reasoning Company Information Table 99. Digital Reasoning Business Overview Table 100. Digital Reasoning AI-based Clinical Trial Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Digital Reasoning AI-based Clinical Trial Solution Product Portfolio Table 102. Digital Reasoning Recent Development Table 103. Insilico Medicine Company Information Table 104. Insilico Medicine Business Overview Table 105. Insilico Medicine AI-based Clinical Trial Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Insilico Medicine AI-based Clinical Trial Solution Product Portfolio Table 107. Insilico Medicine Recent Development Table 108. Insitro Company Information Table 109. Insitro Business Overview Table 110. Insitro AI-based Clinical Trial Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Insitro AI-based Clinical Trial Solution Product Portfolio Table 112. Insitro Recent Development Table 113. Evotec Company Information Table 114. Evotec Business Overview Table 115. Evotec AI-based Clinical Trial Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Evotec AI-based Clinical Trial Solution Product Portfolio Table 117. Evotec Recent Development Table 118. PathAI Company Information Table 119. PathAI Business Overview Table 120. PathAI AI-based Clinical Trial Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. PathAI AI-based Clinical Trial Solution Product Portfolio Table 122. PathAI Recent Development Table 123. Cancer Center.ai Company Information Table 124. Cancer Center.ai Business Overview Table 125. Cancer Center.ai AI-based Clinical Trial Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Cancer Center.ai AI-based Clinical Trial Solution Product Portfolio Table 127. Cancer Center.ai Recent Development Table 128. North America AI-based Clinical Trial Solution Revenue by Type (2021-2026) & (US$ Million) Table 129. North America AI-based Clinical Trial Solution Revenue by Type (2027-2032) & (US$ Million) Table 130. North America AI-based Clinical Trial Solution Revenue by Application (2021-2026) & (US$ Million) Table 131. North America AI-based Clinical Trial Solution Revenue by Application (2027-2032) & (US$ Million) Table 132. North America AI-based Clinical Trial Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. North America AI-based Clinical Trial Solution Revenue by Country (2021-2026) & (US$ Million) Table 134. North America AI-based Clinical Trial Solution Revenue by Country (US$ Million) & (2027-2032) Table 135. Europe AI-based Clinical Trial Solution Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe AI-based Clinical Trial Solution Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe AI-based Clinical Trial Solution Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe AI-based Clinical Trial Solution Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe AI-based Clinical Trial Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Europe AI-based Clinical Trial Solution Revenue by Country (2021-2026) & (US$ Million) Table 141. Europe AI-based Clinical Trial Solution Revenue by Country (US$ Million) & (2027-2032) Table 142. China AI-based Clinical Trial Solution Revenue by Type (2021-2026) & (US$ Million) Table 143. China AI-based Clinical Trial Solution Revenue by Type (2027-2032) & (US$ Million) Table 144. China AI-based Clinical Trial Solution Revenue by Application (2021-2026) & (US$ Million) Table 145. China AI-based Clinical Trial Solution Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia AI-based Clinical Trial Solution Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia AI-based Clinical Trial Solution Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia AI-based Clinical Trial Solution Revenue by Application (2021-2026) & (US$ Million) Table 149. Asia AI-based Clinical Trial Solution Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia AI-based Clinical Trial Solution Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Asia AI-based Clinical Trial Solution Revenue by Region (US$ Million) & (2021-2026) Table 152. Asia AI-based Clinical Trial Solution Revenue by Region (US$ Million) & (2027-2032) Table 153. SAMEA AI-based Clinical Trial Solution Revenue by Type (2021-2026) & (US$ Million) Table 154. SAMEA AI-based Clinical Trial Solution Revenue by Type (2027-2032) & (US$ Million) Table 155. SAMEA AI-based Clinical Trial Solution Revenue by Application (2021-2026) & (US$ Million) Table 156. SAMEA AI-based Clinical Trial Solution Revenue by Application (2027-2032) & (US$ Million) Table 157. SAMEA AI-based Clinical Trial Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. SAMEA AI-based Clinical Trial Solution Revenue by Country (2021-2026) & (US$ Million) Table 159. SAMEA AI-based Clinical Trial Solution Revenue by Country (US$ Million) & (2027-2032) Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. AI-based Clinical Trial Solution Image Figure 2. Global AI-based Clinical Trial Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI-based Clinical Trial Solution Market Size Share 2021 VS 2025 VS 2032 Figure 4. Artificial Narrow Intelligence Image Figure 5. Artificial General Intelligence Image Figure 6. Artificial Super Intelligence Image Figure 7. Global AI-based Clinical Trial Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global AI-based Clinical Trial Solution Market Size Share 2021 VS 2025 VS 2032 Figure 9. Drug Discovery Image Figure 10. Drug Manufacturing Image Figure 11. Drug Marketing Image Figure 12. Diagnosis and Treatment Image Figure 13. Clinical Trials Image Figure 14. Global AI-based Clinical Trial Solution Market Size (US$ Million) & (2021-2032) Figure 15. Global AI-based Clinical Trial Solution Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global AI-based Clinical Trial Solution Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global AI-based Clinical Trial Solution Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global AI-based Clinical Trial Solution Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global AI-based Clinical Trial Solution Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global AI-based Clinical Trial Solution Revenue Market Share by Type (2021-2032) Figure 22. Global AI-based Clinical Trial Solution Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global AI-based Clinical Trial Solution Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global AI-based Clinical Trial Solution Revenue Market Share by Application (2021-2032) Figure 25. North America AI-based Clinical Trial Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America AI-based Clinical Trial Solution Revenue Share by Type (2021-2032) Figure 27. North America AI-based Clinical Trial Solution Revenue Share by Application (2021-2032) Figure 28. North America AI-based Clinical Trial Solution Revenue Share by Country (2021-2032) Figure 29. United States AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe AI-based Clinical Trial Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe AI-based Clinical Trial Solution Revenue Share by Type (2021-2032) Figure 34. Europe AI-based Clinical Trial Solution Revenue Share by Application (2021-2032) Figure 35. Europe AI-based Clinical Trial Solution Revenue Share by Country (2021-2032) Figure 36. Germany AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China AI-based Clinical Trial Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China AI-based Clinical Trial Solution Revenue Share by Type (2021-2032) Figure 46. China AI-based Clinical Trial Solution Revenue Share by Application (2021-2032) Figure 47. Asia AI-based Clinical Trial Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia AI-based Clinical Trial Solution Revenue Share by Type (2021-2032) Figure 49. Asia AI-based Clinical Trial Solution Revenue Share by Application (2021-2032) Figure 50. Asia AI-based Clinical Trial Solution Revenue Share by Region (2021-2032) Figure 51. Japan AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA AI-based Clinical Trial Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA AI-based Clinical Trial Solution Revenue Share by Type (2021-2032) Figure 59. SAMEA AI-based Clinical Trial Solution Revenue Share by Application (2021-2032) Figure 60. SAMEA AI-based Clinical Trial Solution Revenue Share by Country (2021-2032) Figure 61. Brazil AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt AI-based Clinical Trial Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Artificial Narrow Intelligence
  • Artificial General Intelligence
  • Artificial Super Intelligence
Applications
  • Drug Discovery
  • Drug Manufacturing
  • Drug Marketing
  • Diagnosis and Treatment
  • Clinical Trials
Companies covered
  • AiCure
  • Antidote
  • Deep Lens
  • Saama Technologies
  • Trials.ai
  • Deep 6 AI
  • Innoplexus
  • Median Technologies
  • Mendel.ai
  • Phesi
  • Tempus
  • IBM
  • Digital Reasoning
  • Insilico Medicine
  • Insitro
  • Evotec
  • PathAI
  • Cancer Center.ai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI-based Clinical Trial Solution Market by Type
  3. 1.2.1 Global AI-based Clinical Trial Solution Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Artificial Narrow Intelligence
  5. 1.2.3 Artificial General Intelligence
  6. 1.2.4 Artificial Super Intelligence
  7. 1.3 AI-based Clinical Trial Solution Market by Application
  8. 1.3.1 Global AI-based Clinical Trial Solution Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Drug Discovery
  10. 1.3.3 Drug Manufacturing
  11. 1.3.4 Drug Marketing
  12. 1.3.5 Diagnosis and Treatment
  13. 1.3.6 Clinical Trials
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 AI-based Clinical Trial Solution Market Dynamics
  1. 2.1 AI-based Clinical Trial Solution Industry Trends
  2. 2.2 AI-based Clinical Trial Solution Industry Drivers
  3. 2.3 AI-based Clinical Trial Solution Industry Opportunities and Challenges
  4. 2.4 AI-based Clinical Trial Solution Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI-based Clinical Trial Solution Market Perspective (2021-2032)
  2. 3.2 Global AI-based Clinical Trial Solution Growth Trends by Region
  3. 3.2.1 Global AI-based Clinical Trial Solution Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI-based Clinical Trial Solution Market Size by Region (2021-2026)
  5. 3.2.3 Global AI-based Clinical Trial Solution Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI-based Clinical Trial Solution Revenue by Players
  2. 4.1.1 Global AI-based Clinical Trial Solution Revenue by Players (2021-2026)
  3. 4.1.2 Global AI-based Clinical Trial Solution Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI-based Clinical Trial Solution Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI-based Clinical Trial Solution Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI-based Clinical Trial Solution Key Players Headquarters & Area Served
  7. 4.4 Global AI-based Clinical Trial Solution Players, Product Type & Application
  8. 4.5 Global AI-based Clinical Trial Solution Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI-based Clinical Trial Solution Market CR5 and HHI
  11. 4.6.3 2025 AI-based Clinical Trial Solution Tier 1, Tier 2, and Tier 3
5 AI-based Clinical Trial Solution Market Size by Type
  1. 5.1 Global AI-based Clinical Trial Solution Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI-based Clinical Trial Solution Revenue by Type (2021-2032)
  3. 5.3 Global AI-based Clinical Trial Solution Revenue Market Share by Type (2021-2032)
6 AI-based Clinical Trial Solution Market Size by Application
  1. 6.1 Global AI-based Clinical Trial Solution Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI-based Clinical Trial Solution Revenue by Application (2021-2032)
  3. 6.3 Global AI-based Clinical Trial Solution Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AiCure
  2. 7.1.1 AiCure Company Information
  3. 7.1.2 AiCure Business Overview
  4. 7.1.3 AiCure AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AiCure AI-based Clinical Trial Solution Product Portfolio
  6. 7.1.5 AiCure Recent Developments
  7. 7.2 Antidote
  8. 7.2.1 Antidote Company Information
  9. 7.2.2 Antidote Business Overview
  10. 7.2.3 Antidote AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Antidote AI-based Clinical Trial Solution Product Portfolio
  12. 7.2.5 Antidote Recent Developments
  13. 7.3 Deep Lens
  14. 7.3.1 Deep Lens Company Information
  15. 7.3.2 Deep Lens Business Overview
  16. 7.3.3 Deep Lens AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Deep Lens AI-based Clinical Trial Solution Product Portfolio
  18. 7.3.5 Deep Lens Recent Developments
  19. 7.4 Saama Technologies
  20. 7.4.1 Saama Technologies Company Information
  21. 7.4.2 Saama Technologies Business Overview
  22. 7.4.3 Saama Technologies AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Saama Technologies AI-based Clinical Trial Solution Product Portfolio
  24. 7.4.5 Saama Technologies Recent Developments
  25. 7.5 Trials.ai
  26. 7.5.1 Trials.ai Company Information
  27. 7.5.2 Trials.ai Business Overview
  28. 7.5.3 Trials.ai AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Trials.ai AI-based Clinical Trial Solution Product Portfolio
  30. 7.5.5 Trials.ai Recent Developments
  31. 7.6 Deep 6 AI
  32. 7.6.1 Deep 6 AI Company Information
  33. 7.6.2 Deep 6 AI Business Overview
  34. 7.6.3 Deep 6 AI AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Deep 6 AI AI-based Clinical Trial Solution Product Portfolio
  36. 7.6.5 Deep 6 AI Recent Developments
  37. 7.7 Innoplexus
  38. 7.7.1 Innoplexus Company Information
  39. 7.7.2 Innoplexus Business Overview
  40. 7.7.3 Innoplexus AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Innoplexus AI-based Clinical Trial Solution Product Portfolio
  42. 7.7.5 Innoplexus Recent Developments
  43. 7.8 Median Technologies
  44. 7.8.1 Median Technologies Company Information
  45. 7.8.2 Median Technologies Business Overview
  46. 7.8.3 Median Technologies AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Median Technologies AI-based Clinical Trial Solution Product Portfolio
  48. 7.8.5 Median Technologies Recent Developments
  49. 7.9 Mendel.ai
  50. 7.9.1 Mendel.ai Company Information
  51. 7.9.2 Mendel.ai Business Overview
  52. 7.9.3 Mendel.ai AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Mendel.ai AI-based Clinical Trial Solution Product Portfolio
  54. 7.9.5 Mendel.ai Recent Developments
  55. 7.10 Phesi
  56. 7.10.1 Phesi Company Information
  57. 7.10.2 Phesi Business Overview
  58. 7.10.3 Phesi AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Phesi AI-based Clinical Trial Solution Product Portfolio
  60. 7.10.5 Phesi Recent Developments
  61. 7.11 Tempus
  62. 7.11.1 Tempus Company Information
  63. 7.11.2 Tempus Business Overview
  64. 7.11.3 Tempus AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Tempus AI-based Clinical Trial Solution Product Portfolio
  66. 7.11.5 Tempus Recent Developments
  67. 7.12 IBM
  68. 7.12.1 IBM Company Information
  69. 7.12.2 IBM Business Overview
  70. 7.12.3 IBM AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  71. 7.12.4 IBM AI-based Clinical Trial Solution Product Portfolio
  72. 7.12.5 IBM Recent Developments
  73. 7.13 Digital Reasoning
  74. 7.13.1 Digital Reasoning Company Information
  75. 7.13.2 Digital Reasoning Business Overview
  76. 7.13.3 Digital Reasoning AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Digital Reasoning AI-based Clinical Trial Solution Product Portfolio
  78. 7.13.5 Digital Reasoning Recent Developments
  79. 7.14 Insilico Medicine
  80. 7.14.1 Insilico Medicine Company Information
  81. 7.14.2 Insilico Medicine Business Overview
  82. 7.14.3 Insilico Medicine AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Insilico Medicine AI-based Clinical Trial Solution Product Portfolio
  84. 7.14.5 Insilico Medicine Recent Developments
  85. 7.15 Insitro
  86. 7.15.1 Insitro Company Information
  87. 7.15.2 Insitro Business Overview
  88. 7.15.3 Insitro AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Insitro AI-based Clinical Trial Solution Product Portfolio
  90. 7.15.5 Insitro Recent Developments
  91. 7.16 Evotec
  92. 7.16.1 Evotec Company Information
  93. 7.16.2 Evotec Business Overview
  94. 7.16.3 Evotec AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Evotec AI-based Clinical Trial Solution Product Portfolio
  96. 7.16.5 Evotec Recent Developments
  97. 7.17 PathAI
  98. 7.17.1 PathAI Company Information
  99. 7.17.2 PathAI Business Overview
  100. 7.17.3 PathAI AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  101. 7.17.4 PathAI AI-based Clinical Trial Solution Product Portfolio
  102. 7.17.5 PathAI Recent Developments
  103. 7.18 Cancer Center.ai
  104. 7.18.1 Cancer Center.ai Company Information
  105. 7.18.2 Cancer Center.ai Business Overview
  106. 7.18.3 Cancer Center.ai AI-based Clinical Trial Solution Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Cancer Center.ai AI-based Clinical Trial Solution Product Portfolio
  108. 7.18.5 Cancer Center.ai Recent Developments
8 North America
  1. 8.1 North America AI-based Clinical Trial Solution Revenue (2021-2032)
  2. 8.2 North America AI-based Clinical Trial Solution Revenue by Type (2021-2032)
  3. 8.2.1 North America AI-based Clinical Trial Solution Revenue by Type (2021-2026)
  4. 8.2.2 North America AI-based Clinical Trial Solution Revenue by Type (2027-2032)
  5. 8.3 North America AI-based Clinical Trial Solution Revenue Share by Type (2021-2032)
  6. 8.4 North America AI-based Clinical Trial Solution Revenue by Application (2021-2032)
  7. 8.4.1 North America AI-based Clinical Trial Solution Revenue by Application (2021-2026)
  8. 8.4.2 North America AI-based Clinical Trial Solution Revenue by Application (2027-2032)
  9. 8.5 North America AI-based Clinical Trial Solution Revenue Share by Application (2021-2032)
  10. 8.6 North America AI-based Clinical Trial Solution Revenue by Country
  11. 8.6.1 North America AI-based Clinical Trial Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI-based Clinical Trial Solution Revenue by Country (2021-2026)
  13. 8.6.3 North America AI-based Clinical Trial Solution Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI-based Clinical Trial Solution Revenue (2021-2032)
  2. 9.2 Europe AI-based Clinical Trial Solution Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI-based Clinical Trial Solution Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI-based Clinical Trial Solution Revenue by Type (2027-2032)
  5. 9.3 Europe AI-based Clinical Trial Solution Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI-based Clinical Trial Solution Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI-based Clinical Trial Solution Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI-based Clinical Trial Solution Revenue by Application (2027-2032)
  9. 9.5 Europe AI-based Clinical Trial Solution Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI-based Clinical Trial Solution Revenue by Country
  11. 9.6.1 Europe AI-based Clinical Trial Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI-based Clinical Trial Solution Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI-based Clinical Trial Solution Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI-based Clinical Trial Solution Revenue (2021-2032)
  2. 10.2 China AI-based Clinical Trial Solution Revenue by Type (2021-2032)
  3. 10.2.1 China AI-based Clinical Trial Solution Revenue by Type (2021-2026)
  4. 10.2.2 China AI-based Clinical Trial Solution Revenue by Type (2027-2032)
  5. 10.3 China AI-based Clinical Trial Solution Revenue Share by Type (2021-2032)
  6. 10.4 China AI-based Clinical Trial Solution Revenue by Application (2021-2032)
  7. 10.4.1 China AI-based Clinical Trial Solution Revenue by Application (2021-2026)
  8. 10.4.2 China AI-based Clinical Trial Solution Revenue by Application (2027-2032)
  9. 10.5 China AI-based Clinical Trial Solution Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI-based Clinical Trial Solution Revenue (2021-2032)
  2. 11.2 Asia AI-based Clinical Trial Solution Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI-based Clinical Trial Solution Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI-based Clinical Trial Solution Revenue by Type (2027-2032)
  5. 11.3 Asia AI-based Clinical Trial Solution Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI-based Clinical Trial Solution Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI-based Clinical Trial Solution Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI-based Clinical Trial Solution Revenue by Application (2027-2032)
  9. 11.5 Asia AI-based Clinical Trial Solution Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI-based Clinical Trial Solution Revenue by Country
  11. 11.6.1 Asia AI-based Clinical Trial Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI-based Clinical Trial Solution Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI-based Clinical Trial Solution Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI-based Clinical Trial Solution Revenue (2021-2032)
  2. 12.2 SAMEA AI-based Clinical Trial Solution Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI-based Clinical Trial Solution Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI-based Clinical Trial Solution Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI-based Clinical Trial Solution Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI-based Clinical Trial Solution Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI-based Clinical Trial Solution Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI-based Clinical Trial Solution Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI-based Clinical Trial Solution Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI-based Clinical Trial Solution Revenue by Country
  11. 12.6.1 SAMEA AI-based Clinical Trial Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI-based Clinical Trial Solution Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI-based Clinical Trial Solution Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst